Activity of meropenem against antibiotic-resistant or infrequently encountered gram-negative bacilli
Open Access
- 1 November 1991
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 35 (11) , 2410-2414
- https://doi.org/10.1128/aac.35.11.2410
Abstract
Meropenem was compared in vitro with imipenem as well as with several other contemporary beta-lactams, ciprofloxacin, and gentamicin against a group of highly antibiotic resistant members of the family Enterobacteriaceae and a collection of oxidase-positive and/or glucose-nonfermentative gram-negative bacilli. In this study, meropenem was more active than imipenem against isolates of Enterobacter, Klebsiella, Morganella, Providencia, Alcaligenes, Aeromonas, and Pasteurella.Keywords
This publication has 6 references indexed in Scilit:
- Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum beta-lactamaseAntimicrobial Agents and Chemotherapy, 1990
- Extended-spectrum beta-lactamasesAntimicrobial Agents and Chemotherapy, 1989
- In vitro activity and beta-lactamase stability of a new carbapenem, SM-7338Antimicrobial Agents and Chemotherapy, 1989
- Multicenter in vitro evaluation of SM-7338, a new carbapenemAntimicrobial Agents and Chemotherapy, 1989
- In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase IAntimicrobial Agents and Chemotherapy, 1989
- In-vitro studies of meropenemJournal of Antimicrobial Chemotherapy, 1989